The MET Oncogene Network of Interacting Cell Surface Proteins

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• The MET oncogene, encoding the hepatocyte growth factor (HGF) receptor, is implicated in cancer development, invasion, and therapy resistance.
• Its complete biological functions and activation mechanisms are not fully understood.
• MET engages in extensive interactions with various cell surface proteins.

Purpose of the Study:

• To review current knowledge on MET's interactions and their functional impact.
• To focus on how these partnerships affect signaling, therapeutic resistance, and cellular behavior.
• To evaluate emerging combination therapies targeting MET and its interactors.

Main Methods:

• Literature review of MET's interaction network.
• Analysis of functional consequences of MET partnerships.
• Evaluation of clinical potential of combination therapies.

Main Results:

• MET interacts with receptor tyrosine kinases, co-receptors, adhesion molecules, proteases, and other receptors.
• These interactions dynamically modulate MET activation, signaling, trafficking, and degradation.
• The MET network enhances its functional versatility and oncogenic potential.

Conclusions:

• Understanding MET's complex interaction network is key to advancing anti-cancer strategies.
• Targeting MET and its interactors offers potential for overcoming therapeutic resistance.
• Insights into RTK crosstalk are crucial for improving oncology outcomes.